Paul Ruff to Antineoplastic Agents
This is a "connection" page, showing publications Paul Ruff has written about Antineoplastic Agents.
Connection Strength
0,946
-
Breast Cancer Care Quality in South Africa's Public Health System: An Evaluation Using American Society of Clinical Oncology/National Quality Forum Measures. J Glob Oncol. 2019 11; 5:1-16.
Score: 0,164
-
Efficacy and Safety of Sunitinib in Patients with Well-Differentiated Pancreatic Neuroendocrine Tumours. Neuroendocrinology. 2018; 107(3):237-245.
Score: 0,150
-
A phase II study of oral clofazimine in unresectable and metastatic hepatocellular carcinoma. Ann Oncol. 1998 Feb; 9(2):217-9.
Score: 0,146
-
Final results and outcomes by prior bevacizumab exposure, skin toxicity, and hypomagnesaemia from ASPECCT: randomized phase 3 non-inferiority study of panitumumab versus cetuximab in chemorefractory wild-type KRAS exon 2 metastatic colorectal cancer. Eur J Cancer. 2016 11; 68:51-59.
Score: 0,133
-
ASPECCT: panitumumab versus cetuximab for colorectal cancer--authors' reply. Lancet Oncol. 2014 Jul; 15(8):e303.
Score: 0,114
-
Panitumumab versus cetuximab in patients with chemotherapy-refractory wild-type KRAS exon 2 metastatic colorectal cancer (ASPECCT): a randomised, multicentre, open-label, non-inferiority phase 3 study. Lancet Oncol. 2014 May; 15(6):569-79.
Score: 0,112
-
A phase I study of concurrent cisplatin chemotherapy in patients with carcinoma of the cervix receiving pelvic radiotherapy. Int J Gynecol Cancer. 2006 Jul-Aug; 16(4):1614-9.
Score: 0,065
-
Differential modulation by estradiol of P-glycoprotein drug resistance protein expression in cultured MCF7 and T47D breast cancer cells. Anticancer Res. 2002 Jul-Aug; 22(4):2253-9.
Score: 0,049
-
The treatment of AIDS-related cancers. Lancet Oncol. 2003 Sep; 4(9):576-81.
Score: 0,013